Lallemand Pharma

Clinical evidences

PMBL results meta-analysis

The meta-analysis performed on PMBL demonstrated a significant reduction of infections during the 3 months treatment as compared to placebo.

Significant reduction of infections vs placebo (RR -0.513; 95% CI; -0.722 _ -0.303)

Polyvalent mecanical bacterial lysate for the prevention of recurrent respiratory infections. A meta-analysis.
2011, Mario Cazzola & al.

Study design

  • Meta analysis : 2557 patients from 15 randomized clinical trials.